<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03867305</url>
  </required_header>
  <id_info>
    <org_study_id>IDIL/2017/SP-01</org_study_id>
    <nct_id>NCT03867305</nct_id>
  </id_info>
  <brief_title>Evaluation of the Action of MOBIDERM® on Periarticular Edema After Total Knee Prosthesis - Randomized Controlled</brief_title>
  <acronym>MOBŒDEM</acronym>
  <official_title>Evaluation of the Action of MOBIDERM® on Periarticular Edema After Total Knee Prosthesis - Randomized Controlled Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We hypothesize that the use of MOBIDERM® after total knee prosthesis allows a greater and
      faster resorption of periarticular edema:

        -  improvement of knee flexion;

        -  faster functional gain;

        -  faster decrease in postoperative pain by decreasing tissue tension.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 26, 2019</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Knee volume</measure>
    <time_frame>Day -1</time_frame>
    <description>unit: mm3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee volume</measure>
    <time_frame>Day 0</time_frame>
    <description>unit: mm3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee volume</measure>
    <time_frame>Day 1</time_frame>
    <description>unit: mm3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee volume</measure>
    <time_frame>Day 5</time_frame>
    <description>unit: mm3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee volume</measure>
    <time_frame>Day 15</time_frame>
    <description>unit: mm3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee volume</measure>
    <time_frame>Month 1</time_frame>
    <description>unit: mm3</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>visual analog pain scale visual analog pain scale</measure>
    <time_frame>Day 1</time_frame>
    <description>visual scale numbered from 0 to 10 allowing patients to indicate the level of pain felt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual analog pain scale visual analog pain scale</measure>
    <time_frame>Day 3</time_frame>
    <description>visual scale numbered from 0 to 10 allowing patients to indicate the level of pain felt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual analog pain scale visual analog pain scale</measure>
    <time_frame>Day 5</time_frame>
    <description>visual scale numbered from 0 to 10 allowing patients to indicate the level of pain felt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual analog pain scale visual analog pain scale</measure>
    <time_frame>Day 15</time_frame>
    <description>visual scale numbered from 0 to 10 allowing patients to indicate the level of pain felt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual analog pain scale visual analog pain scale</measure>
    <time_frame>Month 1</time_frame>
    <description>visual scale numbered from 0 to 10 allowing patients to indicate the level of pain felt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee injury and Osteoarthritis Outcome (KOOS) score</measure>
    <time_frame>day -1</time_frame>
    <description>The Knee injury and Osteoarthritis Outcome Score (KOOS) is an instrument for measuring patient-reported outcomes. It assesses short-term and long-term consequences of knee injuries and consequences of primary osteoarthritis.The KOOS has 42 elements grouped into five distinct subscales: KOOS Pain ; KOOS Symptoms; KOOS Function, daily life; KOOS Activities, sports and recreation; KOOS quality of life. The KOOS score is a percentage from 0 to 100, with 0 representing extreme problems and 100 representing no problem.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee injury and Osteoarthritis Outcome (KOOS) score</measure>
    <time_frame>day 15</time_frame>
    <description>The Knee injury and Osteoarthritis Outcome Score (KOOS) is an instrument for measuring patient-reported outcomes. It assesses short-term and long-term consequences of knee injuries and consequences of primary osteoarthritis.The KOOS has 42 elements grouped into five distinct subscales: KOOS Pain ; KOOS Symptoms; KOOS Function, daily life; KOOS Activities, sports and recreation; KOOS quality of life. The KOOS score is a percentage from 0 to 100, with 0 representing extreme problems and 100 representing no problem.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee injury and Osteoarthritis Outcome (KOOS) score</measure>
    <time_frame>month 1</time_frame>
    <description>The Knee injury and Osteoarthritis Outcome Score (KOOS) is an instrument for measuring patient-reported outcomes. It assesses short-term and long-term consequences of knee injuries and consequences of primary osteoarthritis.The KOOS has 42 elements grouped into five distinct subscales: KOOS Pain ; KOOS Symptoms; KOOS Function, daily life; KOOS Activities, sports and recreation; KOOS quality of life. The KOOS score is a percentage from 0 to 100, with 0 representing extreme problems and 100 representing no problem.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of knee flexion / extension</measure>
    <time_frame>Day -1</time_frame>
    <description>degree</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of knee flexion / extension</measure>
    <time_frame>Day 0</time_frame>
    <description>degree</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of knee flexion / extension</measure>
    <time_frame>Day 5</time_frame>
    <description>degree</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of knee flexion / extension</measure>
    <time_frame>Day 15</time_frame>
    <description>degree</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of knee flexion / extension</measure>
    <time_frame>Month 1</time_frame>
    <description>degree</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Edema</condition>
  <condition>Arthroplasty, Replacement, Knee</condition>
  <arm_group>
    <arm_group_label>MOBIDERM group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MOBIDERM</intervention_name>
    <description>Use of a MOBIDERM mobilizing band after total knee prosthesis</description>
    <arm_group_label>MOBIDERM group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient requiring a first total knee prosthesis (scheduled between Tuesday and
             Friday).

          -  Patient that has given his/her free and informed consent and signed the consent form.

          -  The patient must be a member or beneficiary of a health insurance plan

          -  The patient is at least 18 years old (≥) and under 90 years old (&lt;).

        Exclusion Criteria:

          -  The subject is in a period of exclusion determined by a previous study (therapeutic
             study)

          -  The subject refuses to sign the consent

          -  It is impossible to give the subject informed information

          -  The patient is under safeguard of justice or state guardianship

          -  The patient is pregnant or breastfeeding

          -  The patient is allergic to latex bandages.

          -  The subject has contralateral amputation, pressure ulcers, severe Obstructive
             Arteriopathy of Lower Limbs, lymphoedema or thromboembolic event of the lower limb
             (ipsilateral and / or contralateral / superficial or deep or detected by postoperative
             Doppler).

          -  The subject has chronic or active wounds or any cause that hinders normal
             rehabilitation or the application of a bandage.

          -  patient with a stroke / Disabling Neurological Pathology, Chronic Immunological
             Pathology / Systemic Disease.

          -  patient with Hepatic insufficiency.

          -  patient with Venous insufficiency (stages 3 and 4).

          -  The patient is on dialysis.

          -  The subject has cognitive or behavioral disorders (Parkinson's disease, cerebellar
             syndrome, opposition, agitation, dementia).

          -  The subject has a history of knee surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sylvie Petiot, MD</last_name>
    <phone>+33(0)4.66.68.39.20</phone>
    <email>sylvie.petiot@chu-nimes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nîmes University Hospital</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anissa MEGZARI, MD</last_name>
      <phone>+33(0)4.66.68.42.36</phone>
      <email>drc@chu-nimes.fr</email>
    </contact>
    <investigator>
      <last_name>Sylvie PETIOT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mylène BLOT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dominique RICHARD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Willy FAGART</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clarisse BELVISI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurélien SAOUIB</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>March 6, 2019</study_first_submitted>
  <study_first_submitted_qc>March 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2019</study_first_posted>
  <last_update_submitted>August 9, 2019</last_update_submitted>
  <last_update_submitted_qc>August 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

